Shiqiang (Caleb) Jin
About Shiqiang (Caleb) Jin
Shiqiang (Caleb) Jin is a Senior Manager of Biostatistics at Bristol Myers Squibb in Princeton, New Jersey, with a background in statistics and experience in the pharmaceutical industry.
Current Role at Bristol Myers Squibb
Shiqiang (Caleb) Jin currently serves as the Senior Manager of Biostatistics at Bristol Myers Squibb. Since starting in this role in April 2021, Jin operates out of Princeton, New Jersey, United States. His responsibilities include overseeing biostatistical analyses, ensuring the integrity and accuracy of data, and contributing to the strategic planning of pharmaceutical research projects.
Previous Work Experience at FDA
Before his current role, Shiqiang (Caleb) Jin worked at the FDA as an ORISE Fellow in 2020. During his two-month tenure in Silver Spring, Maryland, United States, Jin gained valuable experience in regulatory science. This role provided him with insights into federal regulatory processes and methodologies relevant to the pharmaceutical industry.
Academic Role at Kansas State University
Shiqiang (Caleb) Jin served as a Graduate Teaching Assistant at Kansas State University from 2018 to 2020. During these two years, he contributed to the academic growth of students while honing his teaching skills. Jin was involved in instructional activities, grading, and providing academic support to undergraduate students in Statistics.
Educational Background
Shiqiang (Caleb) Jin holds a Doctorate degree in Statistics from Kansas State University, which he pursued from 2014 to 2021. His PhD dissertation focused on Bayesian high-dimensional variable selection. Prior to this, Jin obtained a Master's degree in Applied Statistics from Lanzhou University (2010-2013) and a Bachelor's degree in Economics with a concentration in Statistics from Fuzhou University.
Experience in the Pharmaceutical Industry
In addition to his current role at Bristol Myers Squibb, Shiqiang (Caleb) Jin has accumulated significant experience in the pharmaceutical industry. His work involves biostatistical analysis and data integrity, playing a crucial role in pharmaceutical research and development. Jin's industry experience is augmented by his academic background and regulatory experience at the FDA.